Blog Posts

Fourth Hospital Sues HRSA for Alleged ‘Unlawful’ Authorization of J&J 340B Program Audits

Children’s National Medical Center sued HRSA for approving a drugmaker's 340B audit request.
A Washington, D.C.-based children’s hospital has sued the federal government for authorizing drugmaker Johnson & Johnson (J&J) to perform “unlawful” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Diabetes Drugmakers Urge Federal Appeals Court to Dismiss Health Centers’ 340B Antitrust Lawsuit

Sanofi and three other diabetes drugmakers are urging a federal district court to dismiss 340B antitrust allegations against them.
Four diabetes drugmakers are urging a federal appeals court to uphold a lower court’s decision to dismiss 340B antitrust claims [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eli Lilly and Amgen Announce Refunds, Amgen Issues NDC Change

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.
Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Adds Louisiana to Eligible States for Immediate 340B Enrollment Due to Hurricane Francine 

HHS declared a Public Health Emergency for Louisiana following Hurricane Francine.
Louisiana providers can enroll in the 340B program outside of the formal enrollment period amid disaster relief efforts following Hurricane [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live